Companies: 49,246 Total Market Cap: 132591774254860.43

Qiagen N.V.

NYSE: QGEN
Healthcare Diagnostics & Research
Rank #1995
Market Cap 9.30 B
Volume 5,462
Price 42.96
Change (%) 0.37%
Country or region Netherlands Netherlands

Qiagen N.V.'s latest marketcap:

9.30 B

As of 05/20/2025, Qiagen N.V.'s market capitalization has reached $9.30 B. According to our data, Qiagen N.V. is the 1995th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 9.30 B
Revenue (ttm) 2.00 B
Net Income (ttm) 93.68 M
Shares Out 216.56 M
EPS (ttm) 0.42
Forward PE 18.12
Ex-Dividend Date 01/29/2025
Earnings Date 05/07/2025
Market Cap Chart
Data Updated: 05/20/2025

Qiagen N.V.'s yearly market capitalization.

Qiagen N.V. has seen its market value grow from $1.78 B to $9.30 B since 1998, representing a total increase of 421.31% and an annual compound growth rate (CAGR) of 6.46%.
Date Market Cap Change (%)
05/20/2025 $9.30 B -6.88%
12/31/2024 $9.97 B 0.61%
12/29/2023 $9.91 B -12.73%
12/30/2022 $11.36 B -10.13%
12/31/2021 $12.64 B 3.57%
12/31/2020 $12.20 B 60.05%
12/31/2019 $7.62 B -2.34%
12/31/2018 $7.80 B 7.58%
12/29/2017 $7.26 B 11.12%
12/30/2016 $6.53 B 1.77%
12/31/2015 $6.42 B 16.92%
12/31/2014 $5.49 B -1.74%
12/31/2013 $5.58 B 31.36%
12/31/2012 $4.25 B 32.05%
12/30/2011 $3.22 B -29.04%
12/31/2010 $4.54 B 2.7%
12/31/2009 $4.42 B 28.8%
12/31/2008 $3.43 B 8.51%
12/31/2007 $3.16 B 40.73%
12/29/2006 $2.25 B 30.03%
12/30/2005 $1.73 B 7.89%
12/31/2004 $1.60 B -8.01%
12/31/2003 $1.74 B 133.79%
12/31/2002 $744.50 M -72.04%
12/31/2001 $2.66 B -41.25%
12/30/1999 $4.53 B 153.94%
12/31/1998 $1.78 B

Company Profile

About Qiagen N.V.

Qiagen N.V. is a leading provider of sample-to-insight solutions, transforming biological samples into molecular insights. Headquartered in Venlo, the Netherlands, the company serves customers globally in molecular diagnostics, academia, pharmaceuticals, and applied testing.

Products & Services

  • Sample Technology Consumables: Includes nucleic acid stabilization and purification kits, manual and automated processing for genotyping, gene expression, and viral/bacterial analysis.
  • Immune Response Consumables: Features interferon-gamma release assays for TB testing, post-transplant testing, and viral load monitoring.
  • Oncology & Reproductive Health: Offers assays for prenatal testing, sexually transmitted diseases, and HPV detection.
  • Research PCR Consumables: Quantitative PCR, reverse transcription, and genotyping kits for gene expression and regulation analysis.
  • NGS & Bioinformatics: Provides gene panels, library prep kits, whole genome amplification, and custom genomic services.
  • Instruments & Software: Includes PCR instruments, digital PCR solutions, and software-as-a-service (SaaS) offerings.

Key Highlights

  • Founded in 1984, with a strong focus on innovation in molecular diagnostics.
  • Comprehensive portfolio covering sample processing, analysis, and bioinformatics.
  • Serves diverse markets, including healthcare, research, and applied testing.
Frequently Asked Questions

As of 05/20/2025, Qiagen N.V. (including the parent company, if applicable) has an estimated market capitalization of $9.30 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Qiagen N.V. global market capitalization ranking is approximately 1995 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Netherlands
Founded 1986
IPO Date 06/28/1996
Employees 5,967
CEO Thierry Bernard
Sector Healthcare
Industry Diagnostics & Research
Address Hulsterweg 82
Venlo, 5912 PL
Netherlands
Website https://www.qiagen.com
People Also Watch
TMO
413.68 0.37%
Danaher
196.41 0.37%
Lonza Group AG
680.77 0.37%
IDXX
521.68 0.37%